Nightingale Health Oyj B

HEALTH.HE

Exchange:	HE
Currency	Euro
Fiscal Year End:	June
Sector:	Healthcare
Industry:	Health Information Services
Gic Sector:	Health Care
Gic Group:	Health Care Equipment & Services
Gic Industry:	Health Care Technology
Gic Sub Industry:	Health Care Technology
Description:	Nightingale Health Oyj, a health technology company, offers health data platform that detects disease risks in Finland, the United Kingdom, rest of Europe, the United States, and internationally. The company's Health Check that detects the risks associated with various common chronic diseases from a single blood sample; and Health Check Remote where health check done remotely. It also offers blood analysis, self collection kits, urine analysis, and biomarkers services. It provides its services to research programs, universities, and healthcare providers. The company has research collaboration agreement with ZOE Limited for its blood collection device. Nightingale Health Oyj was incorporated in 2002 and is headquartered in Helsinki, Finland.
Address:	Mannerheimintie 164a, Helsinki, Finland, 00300
Website:	https://nightingalehealth.com
Full Time Employees:	86
Updated On:	2024-11-09

Market Capitalization:	191882800
Market Capitalization Mln:	191.88
EBITDA:	-14055000
Wall Street Target Price:	6.7
Book Value:	1.37
Earnings Share:	-0.29
Most Recent Quarter:	2023-06-30
Operating Margin TTM:	-3.50
Return On Assets TTM:	-0.11
Return On Equity TTM:	-0.19
Revenue TTM:	4358000
Revenue Per Share TTM:	0.07
Quarterly Revenue Growth YOY:	0.36
Gross Profit TTM:	1276000
Diluted Eps TTM:	-0.29